Rodgers Brothers Inc. Amgen Inc Transaction History

Rodgers Brothers Inc.

$725 Million
Q3 2024

A detailed history of Rodgers Brothers Inc. transactions in Amgen Inc stock. As of the latest transaction made, Rodgers Brothers Inc. holds 2,377 shares of AMGN stock, worth $700,097. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,377

Previous 2,377 -0.0%

Holding current value

$700,097

Previous $742,000 3.1%

% of portfolio

0.11%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $23,122 - $28,099	88 Added 3.84%	2,377 $742,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $1.27 Million - $1.57 Million	-5,800 Reduced 71.7%	2,289 $615,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $1,285 - $1,520	6 Added 0.07%	8,089 $1.8 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.39 Million - $1.7 Million	6,160 Added 320.33%	8,083 $1.95 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $559,933 - $623,107	-2,427 Reduced 55.79%	1,923 $468,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $21,927 - $24,257	100 Added 2.35%	4,350 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $661,276 - $756,770	-3,325 Reduced 43.89%	4,250 $956,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $15,283 - $17,906	-72 Reduced 0.94%	7,575 $1.61 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $5,839 - $6,478	25 Added 0.33%	7,647 $1.86 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $1.27 Million - $1.48 Million	5,730 Added 302.85%	7,622 $1.9 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $12,264 - $15,049	-62 Reduced 3.17%	1,892 $446,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $1.07 Million - $1.28 Million	-6,125 Reduced 75.81%	1,954 $378,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $468,093 - $548,711	2,808 Added 53.27%	8,079 $1.49 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $393,573 - $443,642	2,176 Added 70.31%	5,271 $1 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $321,120 - $374,850	-1,800 Reduced 36.77%	3,095 $602,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $116,732 - $131,600	-630 Reduced 11.4%	4,895 $1.02 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $25,073 - $28,163	151 Added 2.81%	5,525 $1.02 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $155,197 - $181,368	916 Added 20.55%	5,374 $916,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $168 - $188	1 Added 0.02%	4,458 $775,000
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $745,611 - $851,287	4,457	4,457 $831,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rodgers Brothers Inc. with notifications on news.

Account

Rodgers Brothers Inc. Amgen Inc Transaction History